The potassium channel KCa3.1 as new therapeutic target for preventing obliterative airway disease after lung transplantation.

Hua X, Deuse T, Wulff H, Chen YJ, Köhler R, Reichenspurner H, Robbins RC, Schrepfer S. The potassium channel KCa3.1 as new therapeutic target for preventing obliterative airway disease after lung transplantation. . Transplantation. 2013, Vol. 95(2), p. 285-2013.